Showing 320 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

PrEP

Truvada or Descovy: which should I take for PrEP?

About HIV
October 2021
PrEP science

What are the side effects of Truvada used for PrEP?

About HIV
October 2021
PrEP science

Islatravir Subdermal Implant for HIV PrEP Has Promising Phase 1 Trial

Editor's pick
Contagion Live
7 October 2021
Weight gain & lipodystrophy

Older version of tenofovir used as PrEP linked to weight loss

News
5 October 2021
PrEP science

Most switches to Descovy PrEP are probably unnecessary and some may be harmful

News
1 October 2021
Kidney problems

People over 50 years old or with existing kidney dysfunction are more likely to get kidney damage when using tenofovir disoproxil-based PrEP

News
21 September 2021
PrEP science

One dose of TAF every three days gets more drug into cells than a daily dose of TDF

News
17 September 2021
PrEP science

First-in-Class NRTTI Demonstrates Potential as Long-Acting Oral PrEP Against HIV

Editor's pick
Contagion Live
13 September 2021
PrEP science

Truvada or Descovy for PrEP? Your Lab Work May Tell You

Editor's pick
POZ
8 September 2021
PrEP science

Conclusive PrEP study in China paves the way for national provision for gay men

News
19 August 2021
Resistance

Transmitted Drug Resistance to Tenofovir and Emtricitabine is declining in China

Editor's pick
Infectious Disease Advisor
12 August 2021
PrEP science

Two PrEP medications are now available. Equally safe/effective. The biggest difference? The price tag.

Editor's pick
Medical Xpress
5 August 2021
Coronavirus

PrEP Study Sees No Link Between Tenofovir and COVID-19

Editor's pick
POZ
28 July 2021
Antibody-based prevention

HIV vaccines and immunotherapies “would be further along” if they had the resources of COVID-19, says leading antibody researcher

News
28 July 2021
Transgender people

Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa

News
22 July 2021
Injectable & long-acting PrEP

Modelling suggests injectable cabotegravir is far more effective than daily oral PrEP for women

News
22 July 2021
Transgender people

How can HIV research better align with the realities of transgender and gender-diverse people?

News
22 July 2021
Injectable & long-acting PrEP

IAS: Merck's long-acting HIV med hits protective levels in phase 2

Editor's pick
FierceBiotech
21 July 2021
PrEP science

PrEP failures in African programmes are rare, but some are happening in people with good adherence

News
21 July 2021
PrEP

PrEP for women in Europe webinar: Part 2

News
5 July 2021
PrEP science

Continuing declines in HIV diagnoses thanks to successful PrEP roll-out in New South Wales

Editor's pick
University of New South Wales
2 July 2021
PrEP

PrEP for women in Europe webinar: Part 1

News
10 June 2021
PrEP science

Users of event-driven PrEP take it when needed, Dutch study finds

News
25 May 2021
HIV prevention policy

The future of antibody-based HIV prevention

Editor's pick
IAVI
10 May 2021